Neil Abdollahian is Chief Business Officer of Cidara Therapeutics, Inc.. Currently has a direct ownership of 57,471 shares of CDTX, which is worth approximately $1.33 Million. The most recent transaction as insider was on Apr 01, 2021, when has been sold 1,469 shares (Common Stock) at a price of $2.66 per share, resulting in proceeds of $3,908. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.5K
0% 3M change
0% 12M change
Total Value Held $1.33 Million

Neil Abdollahian Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2021
SELL
Open market or private sale
$3,908 $2.66 p/Share
1,469 Reduced 2.49%
57,471 Common Stock
Mar 31 2021
BUY
Grant, award, or other acquisition
-
3,500 Added 5.61%
58,940 Common Stock
Jan 05 2021
SELL
Open market or private sale
$5,908 $2.06 p/Share
2,868 Reduced 4.92%
55,440 Common Stock

Also insider at

BOLD
Boundless Bio, Inc.
NA

Neil Abdollahian

Chief Business Officer
San Diego, CA

Track Institutional and Insider Activities on CDTX

Follow Cidara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDTX shares.

Notify only if

Insider Trading

Get notified when an Cidara Therapeutics, Inc. insider buys or sells CDTX shares.

Notify only if

News

Receive news related to Cidara Therapeutics, Inc.

Track Activities on CDTX